Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A9 | P48067 | 3/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.30 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1614173 | 0.83 | L3MBTL1 (0.31) | — | |
| SCHEMBL133173 | 0.81 | CSNK2A1 (0.35) | — | |
| SCHEMBL1615142 | 0.81 | MEN1 (0.31) | — | |
| SCHEMBL8857494 | 0.76 | HTR2C (0.35) | CYP2C9CYP2C19 | |
| SCHEMBL7051377 | 0.74 | HTR1D (0.36) | CYP2C9CYP2C19 | |
| SCHEMBL3159501 | 0.73 | S1PR5 (0.36) | CYP3A4 | |
| SCHEMBL1614823 | 0.73 | MAPT (0.31) | — | |
| SCHEMBL148031 | 0.72 | MAPT (0.33) | — | |
| SCHEMBL8626631 | 0.71 | MEN1 (0.32) | — | |
| SCHEMBL7769310 | 0.70 | PTPRC (0.30) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7740482-B2 | Stable cationically crosslinkable/polymerizable dental composition with a high filler content | BLUESTAR SILICONES FRANCE (FR) | 2010-06-22 | — | — | US | claimed |
| US-20080287562-A1 | Stable cationically crosslinkable/polymerizable dental composition with a high filler content | RHODIA CHIMIE (FR) | 2008-11-20 | — | — | US | claimed |
| US-20050261390-A1 | Stable cationically crosslinkable/polymerizable dental composition with a high filler content | RHODIA CHIMIE (FR) | 2005-11-24 | — | — | US | claimed |
| US-8916624-B2 | Dental compositions crosslinkable/polymerizable by cationic process | BLUESTAR SILICONES FRANCE SAS (FR) | 2014-12-23 | — | — | US | disclosed |
| US-20110189632-A1 | DENTAL COMPOSITIONS CROSSLINKABLE/POLYMERIZABLE BY CATIONIC PROCESS | BLUESTAR SILICONES FRANCE (FR) | 2011-08-04 | — | — | US | disclosed |
| US-7740482-B2 | Stable cationically crosslinkable/polymerizable dental composition with a high filler content | BLUESTAR SILICONES FRANCE (FR) | 2010-06-22 | — | — | US | disclosed |
| US-20080287562-A1 | Stable cationically crosslinkable/polymerizable dental composition with a high filler content | RHODIA CHIMIE (FR) | 2008-11-20 | — | — | US | disclosed |
| US-20050261390-A1 | Stable cationically crosslinkable/polymerizable dental composition with a high filler content | RHODIA CHIMIE (FR) | 2005-11-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080287562-A1 | Stable cationically crosslinkable/polymerizable dental composition with a high filler content | RFC1, RFC2, HNRNPC | SLC6A9 2454/4885CYP3A4 4132/4885CYP2D6 2936/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.